Adu­canum­ab CAS 1384260-65-4

• Iden­ti­fi­ca­tion
• Prop­er­ties
• Safe­ty Data
• Spec­i­fi­ca­tions & Oth­er Information
• Links
• Quick Inquiry

Iden­ti­fi­ca­tion

CAS Number

1384260-65-4

Name

Adu­canum­ab

Prop­er­ties

Safe­ty Data

Sym­bol

WGK Germany

3

MSDS Download

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our 

Known Appli­ca­tion

Adu­canum­ab CAS 1384260-65-4 is a human mon­o­clon­al anti­body and is the first and only Alzheimer’s dis­ease treat­ment to address the clear pathol­o­gy of the dis­ease by reduc­ing amy­loid plaques in the brain. ADUHELM™ is indi­cat­ed for the treat­ment of Alzheimer’s dis­ease. This indi­ca­tion was grant­ed under accel­er­at­ed approval for amy­loid plaque reduc­tion in patients treat­ed with ADUHELM™.

Gen­er­al View of Documents

Links

This prod­uct is devel­oped by our R&D com­pa­ny Wat­son Bio Lim­it­ed (https://​www​.wat​son​-bio​.com/)

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly.